{"id":"https://openalex.org/W2166202391","doi":"https://doi.org/10.1182/asheducation-2007.1.355","title":"Navigating the Evolving Paradigms in the Diagnosis and Treatment of Myeloproliferative Disorders","display_name":"Navigating the Evolving Paradigms in the Diagnosis and Treatment of Myeloproliferative Disorders","publication_year":2007,"publication_date":"2007-01-01","ids":{"openalex":"https://openalex.org/W2166202391","doi":"https://doi.org/10.1182/asheducation-2007.1.355","mag":"2166202391","pmid":"https://pubmed.ncbi.nlm.nih.gov/18024651"},"language":"en","primary_location":{"id":"doi:10.1182/asheducation-2007.1.355","doi":"https://doi.org/10.1182/asheducation-2007.1.355","is_oa":false,"landing_page_url":"https://doi.org/10.1182/asheducation-2007.1.355","pdf_url":null,"source":{"id":"https://openalex.org/S4210206817","display_name":"Hematology","issn_l":"1520-4383","issn":["1520-4383","1520-4391"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320264","host_organization_name":"American Society of Hematology","host_organization_lineage":["https://openalex.org/P4310320264"],"host_organization_lineage_names":["American Society of Hematology"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Hematology","raw_type":"journal-article"},"volume":null,"type":"review","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5039057642","display_name":"Ruben A. Mesa","orcid":"https://orcid.org/0000-0001-5880-7972","observed_orcids":["https://orcid.org/0000-0001-5880-7972"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Ruben A. Mesa","raw_affiliation_strings":["Mayo Clinic, 200 First Street, SW, Rochester, MN 55902, USA. mesa.ruben@mayo.edu"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mayo Clinic, 200 First Street, SW, Rochester, MN 55902, USA. mesa.ruben@mayo.edu","institution_ids":["https://openalex.org/I1330342723"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5039057642"],"corresponding_institution_ids":["https://openalex.org/I1330342723"],"apc_list":null,"apc_paid":null,"fwci":0.3003,"has_fulltext":false,"cited_by_count":17,"citation_normalized_percentile":{"value":0.32400932,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":97},"biblio":{"volume":"2007","issue":"1","first_page":"355","last_page":"362"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11628","display_name":"Myeloproliferative Neoplasms: Diagnosis and Treatment","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11628","display_name":"Myeloproliferative Neoplasms: Diagnosis and Treatment","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10746","display_name":"Platelet Disorders and Treatments","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T13374","display_name":"Hematological disorders and diagnostics","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2711","display_name":"Emergency Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/myeloproliferative-neoplasms","display_name":"myeloproliferative neoplasms","score":0.9409999847412109},{"id":"https://openalex.org/keywords/polycythemia-vera","display_name":"polycythemia vera","score":0.9819999933242798},{"id":"https://openalex.org/keywords/essential-thrombocythemia","display_name":"essential thrombocythemia","score":1.0},{"id":"https://openalex.org/keywords/primary-myelofibrosis","display_name":"primary myelofibrosis","score":1.0},{"id":"https://openalex.org/keywords/jak2-v617f-mutation","display_name":"JAK2 V617F mutation","score":0.9229999780654907},{"id":"https://openalex.org/keywords/jak2-exon-12-mutation","display_name":"JAK2 exon 12 mutation","score":0.9380000233650208},{"id":"https://openalex.org/keywords/who-diagnostic-criteria","display_name":"WHO diagnostic criteria","score":0.890999972820282},{"id":"https://openalex.org/keywords/risk-stratification","display_name":"risk stratification","score":0.8029999732971191},{"id":"https://openalex.org/keywords/antiplatelet-therapy","display_name":"antiplatelet therapy","score":0.8610000014305115},{"id":"https://openalex.org/keywords/myelosuppressive-therapy","display_name":"myelosuppressive therapy","score":0.9100000262260437},{"id":"https://openalex.org/keywords/jak2-inhibitors","display_name":"JAK2 inhibitors","score":0.7620000243186951},{"id":"https://openalex.org/keywords/tyrosine-kinase-inhibitors","display_name":"tyrosine kinase inhibitors","score":0.8790000081062317},{"id":"https://openalex.org/keywords/dna-hypomethylation","display_name":"DNA hypomethylation","score":0.8859999775886536},{"id":"https://openalex.org/keywords/immunomodulation","display_name":"immunomodulation","score":0.7149999737739563},{"id":"https://openalex.org/keywords/myelofibrosis-progression","display_name":"myelofibrosis progression","score":0.7179999947547913},{"id":"https://openalex.org/keywords/acute-leukemia","display_name":"acute leukemia","score":0.8130000233650208}],"concepts":[{"id":"https://openalex.org/C2910274570","wikidata":"https://www.wikidata.org/wiki/Q1898104","display_name":"Myeloproliferative Disorders","level":2,"score":0.5946673154830933},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.49265486001968384},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.29505831003189087}],"mesh":[{"descriptor_ui":"D000465","descriptor_name":"Algorithms","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002986","descriptor_name":"Clinical Trials as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009154","descriptor_name":"Mutation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009196","descriptor_name":"Myeloproliferative Disorders","qualifier_ui":"Q000175","qualifier_name":"diagnosis","is_major_topic":true},{"descriptor_ui":"D009196","descriptor_name":"Myeloproliferative Disorders","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D009196","descriptor_name":"Myeloproliferative Disorders","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":true},{"descriptor_ui":"D019175","descriptor_name":"DNA Methylation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1182/asheducation-2007.1.355","doi":"https://doi.org/10.1182/asheducation-2007.1.355","is_oa":false,"landing_page_url":"https://doi.org/10.1182/asheducation-2007.1.355","pdf_url":null,"source":{"id":"https://openalex.org/S4210206817","display_name":"Hematology","issn_l":"1520-4383","issn":["1520-4383","1520-4391"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320264","host_organization_name":"American Society of Hematology","host_organization_lineage":["https://openalex.org/P4310320264"],"host_organization_lineage_names":["American Society of Hematology"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Hematology","raw_type":"journal-article"},{"id":"pmid:18024651","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/18024651","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Hematology. American Society of Hematology. Education Program","raw_type":"Journal Article"},{"id":"pmh:oai:CiteSeerX.psu:10.1.1.537.7151","doi":null,"is_oa":false,"landing_page_url":"http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.537.7151","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"http://asheducationbook.hematologylibrary.org/content/2007/1/355.full.pdf","raw_type":"text"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":46,"referenced_works":["https://openalex.org/W1421162947","https://openalex.org/W1581000033","https://openalex.org/W1970553871","https://openalex.org/W1972476718","https://openalex.org/W1980568348","https://openalex.org/W1991277248","https://openalex.org/W1996591949","https://openalex.org/W2003973314","https://openalex.org/W2010253328","https://openalex.org/W2012307188","https://openalex.org/W2015959969","https://openalex.org/W2025614458","https://openalex.org/W2028961479","https://openalex.org/W2036058848","https://openalex.org/W2042473102","https://openalex.org/W2047079894","https://openalex.org/W2047476150","https://openalex.org/W2049145190","https://openalex.org/W2049963179","https://openalex.org/W2056777053","https://openalex.org/W2057360098","https://openalex.org/W2069651950","https://openalex.org/W2080024052","https://openalex.org/W2084329775","https://openalex.org/W2086511628","https://openalex.org/W2099264304","https://openalex.org/W2112316414","https://openalex.org/W2113537576","https://openalex.org/W2119160082","https://openalex.org/W2123587611","https://openalex.org/W2125469922","https://openalex.org/W2129219546","https://openalex.org/W2139133547","https://openalex.org/W2143258215","https://openalex.org/W2144664431","https://openalex.org/W2146505525","https://openalex.org/W2153661889","https://openalex.org/W2159962994","https://openalex.org/W2167405925","https://openalex.org/W2320032845","https://openalex.org/W2520967125","https://openalex.org/W2557857296","https://openalex.org/W2559338865","https://openalex.org/W2576053239","https://openalex.org/W3114368461","https://openalex.org/W4230678169"],"related_works":["https://openalex.org/W2085325045","https://openalex.org/W1992197271","https://openalex.org/W2019068255","https://openalex.org/W2029944177","https://openalex.org/W2163617204","https://openalex.org/W1996716040","https://openalex.org/W2551514518","https://openalex.org/W2144806169","https://openalex.org/W3031926684","https://openalex.org/W2032143191"],"abstract_inverted_index":{"The":[0,64,202],"diagnosis":[1],"and":[2,17,29,53,77,120,189],"management":[3,96],"of":[4,10,26,35,45,61,79,97,110,115,133,175,180,205,211],"the":[5,33,36,75,80,94,108,130,134,167,173,209,212],"BCR-ABL-negative":[6],"myeloproliferative":[7],"disorders":[8],"(MPDs)":[9],"polycythemia":[11],"vera":[12],"(PV),":[13],"essential":[14],"thrombocythemia":[15],"(ET),":[16],"primary":[18],"myelofibrosis":[19,141],"(PMF)":[20],"are":[21,151,195],"at":[22,153,160],"an":[23],"explosive":[24],"crossroads":[25],"scientific":[27,91],"investigation":[28],"evolving":[30],"paradigms":[31],"since":[32],"discovery":[34,44],"tyrosine":[37,176],"kinase-activating":[38],"JAK2V617F":[39],"mutation":[40],"in":[41,74,186,200],"2005.":[42],"Additional":[43],"relevant":[46],"molecular":[47,69],"lesions":[48],"(JAK2":[49],"exon":[50],"12":[51],"mutations":[52],"c-MplW515L/K)":[54],"have":[55,72],"only":[56],"further":[57],"enriched":[58],"our":[59],"understanding":[60],"MPD":[62],"pathogenesis.":[63],"improved":[65],"diagnostic":[66,85],"certainty":[67],"these":[68,90],"markers":[70],"provide":[71],"resulted":[73],"modification,":[76],"simplification,":[78],"World":[81],"Health":[82],"Organization":[83],"(WHO)":[84],"algorithms":[86],"for":[87,149],"MPDs.":[88],"Despite":[89],"advances,":[92],"however,":[93],"initial":[95],"MPDs":[98,135,150,213],"continues":[99],"to":[100,106,136,138,166,197],"rely":[101],"upon":[102],"a":[103,154],"risk-based":[104,121],"strategy":[105],"minimize":[107],"risk":[109],"vascular":[111],"events":[112],"with":[113,157,192,219],"control":[114],"erythrocytosis,":[116],"targeted":[117,147],"antiplatelet":[118],"therapy,":[119],"myelosuppressive":[122],"therapy.":[123],"No":[124],"current":[125],"medical":[126],"therapy":[127],"has":[128],"altered":[129],"natural":[131],"trend":[132],"lead":[137],"overt":[139],"severe":[140],"or":[142,172],"acute":[143],"leukemia.":[144],"Investigations":[145],"into":[146],"therapies":[148],"proceeding":[152],"brisk":[155],"pace":[156],"agents":[158,194],"aimed":[159],"immunomodulation,":[161],"decreasing":[162],"marrow":[163],"stromal":[164],"reaction":[165],"aberrant":[168],"clone,":[169],"DNA":[170],"hypomethylation,":[171],"inhibition":[174,179],"kinases.":[177],"Specific":[178],"JAK2":[181,206],"itself":[182],"appears":[183],"promising":[184],"by":[185],"vitro":[187],"investigations,":[188],"clinical":[190],"trials":[191],"multiple":[193],"planned":[196],"commence":[198],"enrollment":[199],"2007.":[201],"potential":[203],"impact":[204],"inhibitors":[207],"on":[208],"manifestations":[210],"is":[214,217],"unclear,":[215],"but":[216],"awaited":[218],"great":[220],"interest.":[221]},"counts_by_year":[{"year":2018,"cited_by_count":1},{"year":2016,"cited_by_count":1},{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":3}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}